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Background-—Recent longitudinal work suggests that weight change is an important risk factor for inflammation across the full
range of BMI. However, few studies have examined whether the risk of inflammation differs by patterns of weight gain over time.
Using latent class trajectory analysis, we test whether patterns of weight gain are associated with elevated high-sensitivity C-
reactive protein (hs-CRP 2–10 mg/L).
Methods and Results-—Data come from China Health and Nutrition Survey (CHNS) participants (n=5536), aged 18 at baseline to
66 years in 2009, with measured weight over 18 years. Latent class trajectory analysis was used to identify weight-change
trajectories in 6 age and sex strata. Multivariable general linear mixed-effects models fit with a logit link were used to assess the risk
of elevated hs-CRP across weight trajectory classes. Models were fit within age and sex strata, controlling for baseline weight, adult
height, and smoking, and included random intercepts to account for community-level correlation. Steeper weight-gain trajectories
were associated with greater risk of elevated hs-CRP compared to more moderate weight-gain trajectories in men and women.
Initially high weight gain followed by weight loss was associated with lower risk of elevated hs-CRP in women aged 18 to 40.
Conclusions-—Latent class trajectory analysis identified heterogeneity in adult weight change associated with differential risk of
inflammation independently of baseline weight and smoking. These results suggest that trajectories of weight gain are an
important clinical concern and may identify those at risk for inflammation and the development of cardiometabolic disease. ( J Am
Heart Assoc. 2016;5:e003262 doi: 10.1161/JAHA.116.003262)
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I ncreasing evidence establishes chronic, low-grade inflam-mation as an important risk factor for the development of
cardiometabolic disease.1–5 Elevations in C-reactive protein
(CRP), an acute-phase protein commonly used as a marker of
systemic inflammation, predict mortality from all causes of
heart disease1 and are associated with components of the
metabolic syndrome including high blood pressure, elevated
fasting glucose, insulin resistance, and impaired fibrinolysis.3
Overweight and obesity appear to be major drivers of
inflammation, with a number of recent studies demonstrating
a strong association between BMI category and CRP levels.6,7
Similar associations have been seen across samples and
ethnic groups7–10 and may reflect the production of proin-
flammatory cytokines stimulating CRP production11,12 by
adipose, and particularly visceral adipose, tissue.13–15
The bulk of the literature on the association between
inflammation and obesity has been cross-sectional, but recent
longitudinal work suggests that weight gain is an important risk
factor for elevations in CRP across all BMI classes. CRP
increased linearly with weight over approximately a decade of
follow-up in middle-aged American6 and British adults,16 with a
somewhat stronger effect seen in those already overweight or
obese at baseline.6 Similarly, the prevalence of elevated CRP
was highest among women gaining the greatest amounts of
weight compared to women maintaining their weight or gaining
fewer kilograms across 20 to 40 years, measured retrospec-
tively.17,18 Conversely, weight loss has been associated with
reduced CRP levels across a range of weights, interventions
(diet, physical activity, surgery, etc), and lengths of follow-
up.19,20 However, these studies have generally been limited to 2
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measures of weight due to short periods of follow-up8,21 or
reliance on self-reported weight from earlier in the lifecy-
cle17,18,22 and have not been able to examine the pattern of
weight gain as a risk factor for inflammation. Yet, weight-gain
trajectory may play an important role in determining risk of
inflammation because weight-gain trajectories have been
associated with other cardiometabolic risk factors including
obesity23,24 and markers of insulin resistance.25,26 Under-
standingwhether different patterns of weight gain—early onset
maintained over the lifecycle or recent rapid gains, for instance
—predict inflammation is important for understanding the
etiology of inflammation with weight change, identifying groups
at particularly high risk, and shaping prevention strategies.
Previous research on weight gain and inflammation has
generally been limited to high-income Western countries;
however, the rapid emergence of obesity and its comorbidities
in developing countries may provide a critical context for
understanding the impact of heterogeneity in patterns of
weight gain on cardiometabolic risk. Thus, we take advantage
of repeated measures of weight collected over 2 decades in
5536 adult participants (aged 18–66 years) in the China
Health and Nutrition Survey27 to examine how patterns of
weight gain shape current inflammation. We use latent class
trajectory analysis (LCTA) to generate empirically derived
weight-change trajectories across sex and age strata and test
whether these trajectories are associated with the differential
risk of elevated hs-CRP (2–10 mg/L).
Materials and Methods
The China Health and Nutrition Survey
The China Health and Nutrition Survey (CHNS) collected
health data in 228 communities across 9 diverse provinces
(Guangxi, Guizhou, Heilongjiang, Henan, Hubei, Hunan,
Jiangsu, Liaoning, and Shandong). Survey procedures have
been described elsewhere.27 Briefly, counties in the 9
provinces were stratified by income. Multistage random
cluster sampling was used to select 4 counties in each
province. Villages and small towns within counties and urban
and suburban neighborhoods within cities were selected
randomly into primary sampling units that were politically and
geographically classified based on State Statistical Office
definitions. The surveyed provinces represent 56% of the
Chinese population. Eight rounds of surveys were conducted
from 1989 to 2009, and fasting blood was first collected in
the 2009 survey. This study protocol and the analysis were
approved by the Institutional Review Board at the University of
North Carolina at Chapel Hill, the China-Japan Friendship
Hospital, Ministry of Health of China, and Institute of Nutrition
and Food Safety, China Centers for Disease Control. Subjects
gave informed consent for participation.
Analysis Sample
The analytic sample includes adult men and nonpregnant
women with measured hs-CRP at the 2009 exam, between
the ages of 18 at the baseline exam and <66 years at the
2009 exam, with at least 2 repeat anthropometric measures
and with hs-CRP ≤10 mg/L, an accepted indicator of current
infection.4 A total of 8149 adults had measured biomarkers
and were <66 years of age at the 2009 exam. Of these,
6470 had at least 2 weight measures and could be assigned
to a weight trajectory, 6457 were not currently pregnant,
and 5536 had CRP ≤10 mg/L. The majority of the sample
(56%) had 5 or more repeated weight measures (range 2–7),
yielding a final sample of 5536 participants with 26 118
observations. Final age, baseline weight, average adult
height, urbanization, and smoking differed significantly
between the total adult and analytic sample in 2009
(Table S1). Those excluded tended to be younger, more
urban, and less likely to smoke.
Measures
High-Sensitivity C-Reactive Protein
Blood (12 mL) was collected by venipuncture after an
overnight fast. Whole blood was immediately centrifuged,
and plasma and serum samples were frozen and stored for
analysis. The hs-CRP was measured using the immunoturbid-
metric method (Hitachi 7600 automated analyzer, Hitachi,
Tokyo, Japan) with Denka Seike (Tokyo, Japan) reagents. All
samples were processed in a national lab in Beijing, awarded a
medical laboratory accreditation certificate (ISO
15189:2007). Values of >2 mg/L were considered indicative
of inflammation because values above this cut point are
associated with high risk of future cardiovascular events4,5
and have been previously used in Asian samples.10
Anthropometry
Weight and height were collected by 2 trained health workers
using standard protocols. Weight was measured without
shoes and in light clothing to the nearest 0.1 kg on a
calibrated beam scale. Height was measured without shoes to
the nearest 0.2 cm using a portable SECA stadiometer and
averaged across all repeated measures for analyses. BMI was
calculated as kg/m2.
Latent Class Trajectories
Weight-change trajectories were identified using latent class
trajectory analysis (LTCA), a method that has been used to
identify otherwise unobserved trajectory classes in epidemi-
ological data.28 LCTA has the advantage of identifying distinct
groups with similar underlying trajectories.29–31 These
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trajectories can vary in functional form across a number of
different order polynomials, allowing the best-fitting polyno-
mial form to be specified for each trajectory separately. This
property may be particularly important in our sample given the
differential age-related patterns of weight gain observed over
the past 20 years in China.32 The procedure used to derive
the trajectories is more fully described elsewhere.33 Briefly,
LCTA was conducted using SAS version 9.2 (SAS Institute,
Cary, NC) with the TRAJ procedure.34,35 We modeled weight
change, calculated as current weight minus baseline weight,
over time for 6 sex and age subgroups corresponding to the
following baseline age categories: 18 to <30, 30 to <40, and
40 to <66 (with a maximum age of 66 at the 2009 visit). All
trajectories for the individual sex and age strata were
assumed to follow the same order polynomial, with different
models fit for linear, quadratic, cubic, and fifth-order polyno-
mials. The best-fit models were chosen based on (1) lowest
Bayesian information criteria (BIC) and (2) each trajectory
containing at least 2% predicted sample size. Because these
trajectories are empirically derived, the number of resulting
trajectories is expected to vary between sex and age strata if
underlying patterns differ across sex and age. Once weight
gain trajectories were determined, individuals were assigned
to the class with the highest posterior probability.29 Trajectory
membership was then treated as an indicator variable in the
current analyses.
Demographic and Clinical Variables
Demographic variables included income, urbanization, and
smoking measured as ever/never and number of cigarettes
smoked per day. Income was derived from total household
income and measured in yuan.36 Urbanicity was defined using
a multidimensional 12-component urbanization index captur-
ing community-level physical, social, cultural, and economic
environments.37 To more fully describe the clinical history of
the sample, we include descriptive data on medical history of
hypertension or diabetes mellitus and laboratory data assess-
ing lipid profiles, glucose levels, renal function, and liver
function. Because clinical diagnoses are less common in
China, we defined as hypertensive individuals with a diagnosis
of hypertension or currently taking antihypertensive medica-
tion or a mean systolic blood pressure ≥140 mm Hg or
diastolic blood pressure ≥90 mm Hg. Similarly, we defined
individuals as diabetic if they had been diagnosed with
diabetes mellitus, were taking insulin or other medications, or
had a fasting blood glucose level ≥7 nmol/L. Cardiometabolic
biomarkers including low-density lipoprotein (LDL), high-
density lipoprotein (HDL), triglycerides (TG), total cholesterol
(TC), glucose, creatinine (CRE), and alanine aminotransferase
(ALT) have been previously described in detail for this
sample38,39 and are presented to provide context only.
Statistical Analyses
Analyses were done in R version 2.13 statistical software (R
Development Core Team, Vienna, Austria) using the SAS-
defined weight gain trajectory classes. Demographic variables
are summarized across age and sex strata with percentages
for categorical variables and with the median and 25th and
75th percentiles for continuous variables. The odds of
elevated hs-CRP were compared across weight-trajectory
classes within age and sex strata in multivariable general
linear mixed-effects models fit with a logit link with covariates
corresponding to measures that were determined a priori to
be of interest: baseline weight (included as a quadratic term),
height (averaged across all repeated measures), and, for men,
smoker status (ever/never) and current number of cigarettes.
Random intercepts were included to account for potential
community-level correlation. Models were structured similarly
across all age and sex groups, although smoking variables
were not included in models for women given their low
prevalence of smoking (3.3%). We tested whether the effect of
weight-gain trajectories was moderated by their relationship
with weight by testing for significant interaction effects
(P<0.05) between baseline weight (measured linearly) and
trajectory group with a likelihood ratio test. The combination
of baseline weight by trajectory effectively describes individ-
ual weight in 2009. No interaction terms were significant at
the P<0.05 level, and thus, no interaction terms were retained
in the final models.
Expected percentage with elevated hs-CRP with 95%
confidence intervals is presented for each trajectory across
age and sex strata for never smokers along with the sex-
specific mean baseline weight (men 61 kg, women 54 kg) and
the sex-specific mean average adult height (men 167 cm,
women 156 cm), living in an average community. For ease of
interpretation, trajectories characterized by weight gain are
presented in blue, stable trajectories in gray, and weight-loss
trajectories in maroon. For each model an overall test for
weight trajectories was performed; statistically significant
differences in risk of elevated hs-CRP for each given weight-
class trajectory are indicated with asterisks. For models
where this overall test was significant, pairwise comparisons
between groups were also conducted.
Sensitivity analysis was conducted excluding individuals
(n=210) who were currently taking medications identified as
having anti-inflammatory properties,40 including statins, anti-
coagulants, antibiotics, cancer treatment, glucocorticoids, sex
hormones, nonsteroidal anti-inflammatories, and aspirin.
Finally, we conducted a simulation study to test the stability
of the ranking of the risk of elevated hs-CRP by trajectory
group. Ranks were assigned to the groups by their associated
probability of elevated hs-CRP, with a rank of 1 given to the
trajectory class with the highest probability. Ranks were
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recorded for each group, and this process was repeated
10 000 times to determine the frequency of each ranking for
each trajectory class.
Results
Subject Characteristics
Overall median age was 48.8 years, ranging from 21 to 66 in
2009 (Table 1). Median duration of follow-up was 12 years,
ranging from 9 to 18 (Table 1; further information on baseline
year for each age-sex stratum is presented in Table S2).
Median baseline weight, 60 kg for men and 53.3 kg for
women, was higher in the older relative to the younger age
groups, whereas median adult height, 167.0 cm for men and
156.6 cm for women, was lower in the older age groups.
Among women, urbanicity and proportion of ever smokers
were higher, and household income lower, in the older age
groups. The prevalence of elevated hs-CRP was higher in the
older age groups for both sexes (Table 2). The prevalence of
hypertension and diabetes mellitus and most cardiometabolic
biomarkers increased with age with the exception of HDL and
ALT, which declined with age, and creatinine, which remained
relatively constant.
Weight Trajectories and hs-CRP
In men aged 18 to <30 at baseline (Figure 1A and 1B), the
risk of elevated hs-CRP significantly varied across trajectory
classes (P=0.001; Table 3), despite some overlap in confi-
dence intervals. Pairwise comparisons indicated that the risk
of elevated hs-CRP is highest in the trajectory groups with
steepest weight change (groups 3 and 4) relative to the initial
weight loss group (group 1) and the group with stable, lower
weight gain (group 2). Similar patterns were observed in men
aged 30 to <40 and 40 to 66 at baseline: those with the
steepest weight-change trajectories have the highest risk of
elevated hs-CRP (Figure 1C through 1F). However, these
patterns were not statistically significant in the 2 older age
strata.
Across age strata in women, those with the steepest
weight-change trajectories had the greatest risk of elevated
hs-CRP despite some overlap in confidence intervals (Fig-
ure 2A through 2F). In women aged 18 to <30 at baseline
(Figure 2A and 2B), the risk of elevated hs-CRP is significantly
higher in the steeper weight-gain trajectories (groups 4 and 6)
compared to the maintenance group (group 2) and is highest
in the steepest weight-gain trajectory (group 6) relative to all
other groups (Table 3). Compared to those groups with high
weight gain that continue to gain weight (groups 4 and 6), the
group with high early weight gain and subsequent loss (group
5) has a significantly lower risk of elevated hs-CRP. Ta
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These patterns are repeated in women aged 30 to <40 and
40 to 66, with the steepest weight-change trajectories
(groups 4 and 6 and groups 3 and 4, respectively) having
the highest risk of elevated hs-CRP (Figure 2C through 2F)
compared to the maintenance referent group (Group 2).
Similarly, in the 30- to <40-year-old strata, the high initial
weight-gain and subsequent weight-loss group (group 5) had
lower risk of elevated hs-CRP than the high weight gain
groups (groups 4 and 6).
Sensitivity Testing and Model Simulation
Sensitivity analysis excluding 210 individuals who reported
taking medications with anti-inflammatory properties (Figures
S1 and S2) revealed no strong differences in point estimates
or confidence intervals from our main analyses. Results from
our simulation study examining the relative ranking of
trajectories for risk of elevated CRP across 10 000 model
runs are shown in Figure S3. Groups with the highest risk of
elevated CRP are labeled with rank 1, and the colored bands
show the stability of the ranking of the groups. For example,
for women with baseline age 18 to <30, the group with the
highest weight trajectory (group 6) always has the highest risk
of inflammation, the group with initial weight loss (group 1)
always has the lowest risk, and the groups with more
intermediate gains have tended to be classified in their central
positions. Results for the younger male strata were even more
consistent, with groups retaining their relative ranking in the
majority of cases in each simulation.
Discussion
Our empirically derived weight-gain trajectories, measured over
18 years in a longitudinal sample of adults from the China
Health and Nutrition Survey, identified patterns of weight
change across age and sex strata that were differentially
predictive of elevated hs-CRP levels. Steeper weight-gain
trajectories were associated with elevated risk of inflammation
and weight loss associated with lower risk of inflammation
compared tomoremoderateweight gain trajectories, even after
adjustment for initial weight, height, and smoking behaviors.
Across sex and age strata, we found that those with higher,
steeper weight gains were more likely to have elevated hs-
CRP regardless of initial weight. These results are similar to
other longitudinal studies of weight change and inflammation,
which have found that individuals with the highest weight gain
over follow-up have the greatest odds of elevated CRP.17,18,41
In addition to these similarities with the published literature,
we also identified unique classes of weight change associated
with risk of inflammation. Among men aged 18 to 30 at
baseline, risk of elevated hs-CRP was similar in those who
gained weight more recently and rapidly (group 3) comparedTa
bl
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Figure 1. The probability of elevated hs-CRP (A, C, and E) by weight-change trajectory (B, D, and F) across 3 age
strata inmen: (A and B) 18 to 29 years; (C and D) 30 to 39 years; (E and F) 40 to 66 years. Expected percentage (95%
confidence interval) with elevated hs-CRP are presented from left to right corresponding to the relative level of weight
change in the color-matched trajectory. For ease of interpretation, trajectories characterized by weight gain are
presented in blue, stable trajectories in gray, and weight-loss trajectories in maroon. The number of participants in
each class is presented at the bottom of each figure. The trajectory numbers under graphs in A, C, and E correspond to
the similarly colored trajectories in B, D, and F, respectively. Significant effects of the trajectories are indicated with an
asterisk. CRP indicates C-reactive protein; hs-CRP, high-sensitivity C-reactive protein.
DOI: 10.1161/JAHA.116.003262 Journal of the American Heart Association 6
Weight Gain Patterns and hs-CRP Thompson et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
to those with the highest levels of weight gain (group 4)
despite overall gains and final weights that were 8 to 10 kg
lower. It has previously been proposed that more rapid weight
gain may produce greater inflammation in the adipose
tissue,17 an interpretation supported by rodent models
showing that rapid-onset, high-fat, high-sugar diet-induced
obesity leads to a dramatic increase in proinflammatory
macrophages42 and the rapid expression of inflammation-
related genes43 in adipose tissue. Our results provide
preliminary evidence that rapid weight gain may place
individuals at greater risk for inflammation and contrast those
results recently described for US adults, in whom the severity
of obesity, rather than its duration, was associated with
elevated cardiometabolic risk.22
Table 3. Intertrajectory Differences in Probability of Elevated hs-CRP (2–10 mg/L)
Strata Trajectory Trajectory Name N
Predicted Probability
CRP >2 (95% CI)
Overall
P Value*
Group
Differences†
Interaction
P Value‡
Men, y
18 to <30 1 Initial weight loss 81 0.07 (0.04–0.15) 0.001 3 4 0.83
2 Stable, low weight 545 0.11 (0.08–0.15) 3 4
3 Steep weight gain 251 0.18 (0.13–0.25) 1 2
4 Steepest weight gain 41 0.25 (0.14–0.42) 1 2
30 to <40 1 Initial weight loss 47 0.15 (0.07–0.28) 0.30 No group
differences
observed
0.18
3 Stable low weight 307 0.17 (0.12–0.23)
2 Stable weight gain 363 0.17 (0.12–0.23)
4 Steep weight gain 120 0.23 (0.15–0.33)
5 Steepest weight gain 15 0.35 (0.15–0.63)
40 to 66 1 Initial weight loss 27 0.19 (0.08–0.37) 0.71 No group
differences
observed
0.66
2 Stable low weight 259 0.19 (0.14–0.26)
3 Stable weight gain 390 0.18 (0.13–0.23)
4 Steep weight gain 137 0.22 (0.15–0.30)
5 Steepest weight gain 36 0.25 (0.13–0.42)
Women, y
18 to <30 1 Weight loss 87 0.03 (0.01–0.09) <0.0001 2 3 4 5 6 0.43
2 Maintenance 322 0.12 (0.08–0.17) 1 4 6
3 Stable weight gain 344 0.14 (0.10–0.19) 1 6
5 Weight gain and loss 43 0.13 (0.05–0.28) 1 6
4 Steep weight gain 121 0.20 (0.13–0.30) 1 2 6
6 Steepest weight gain 18 0.78 (0.53–0.92) 1 2 3 4 5
30 to <40 1 Weight loss 24 0.18 (0.07–0.37) 0.006 0.10
2 Maintenance 153 0.11 (0.07–0.17) 4 6
3 Stable weight gain 520 0.16 (0.12–0.19) 4 6
4 Steep weight gain 311 0.23 (0.18–0.29) 2 3
6 Steepest weight gain 39 0.32 (0.19–0.50) 2 3
5 Weight gain and loss 22 0.16 (0.05–0.40)
40 to 66 1 Weight loss 38 0.21 (0.12–0.36) 0.0002 4 0.29
2 Maintenance 439 0.19 (0.15–0.23) 3 4
3 Stable weight gain 374 0.27 (0.23–0.32) 2 4
4 Steepest weight gain 44 0.48 (0.33–0.63) 1 2 3
*Overall test of trajectory significance in full models adjusted for baseline weight (quadratic), height (averaged across repeated measures), smoker status (ever/never) and current number
of cigarettes (both for men only), and a random intercept for community.
†Numbers indicate groups that were significantly different in pairwise comparison tests. For example, for men aged 18 to 30, group 1 differed significantly from groups 3 and 4.
‡Likelihood ratio test for interaction effects between baseline weight (measured linearly).
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Figure 2. The probability of elevated hs-CRP (A, C, and E) by weight-change trajectory (B, D, and F) across 3
age strata in women: (A and B) 18 to 29 years; (C and D) 30 to 39 years; (E and F) 40 to 66 years. Expected
percentages (95% confidence interval) with elevated hs-CRP are presented from left to right corresponding to
the relative level of weight change in the color-matched trajectory. For ease of interpretation, trajectories
characterized by weight gain are presented in blue, stable trajectories in gray, and weight-loss trajectories in
maroon. The number of participants in each class is presented at the bottom of each figure. The trajectory
numbers under graphs in A, C, and E correspond to the similarly colored trajectories in figures B, D, and F,
respectively. Significant effects of the trajectories are indicated with an asterisk. CRP indicates Creactive
protein; hs-CRP, high-sensitivity C-reactive protein.
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Despite similar weight-gain trajectories across age strata for
men, and in contrast to the significant results across all age
strata in women, we did not find a significant association
between weight-gain trajectories and risk of inflammation in
men in the 2 older age strata (30 to <40 and 40–66 years).
These results suggest that, for men, steeper weight gains at
younger ages may be riskier for the development of inflamma-
tion than weight gain at older ages. This association between
weight gain and inflammation in younger, but not older, men
may reflect a cohort-related difference in the composition of
excess weight gain. Recent studies document that waist
circumference has increased disproportionally to body mass in
Chinese men over the past 15 years.44,45 Thus, the weight gain
seen in our younger male age strata may reflect greater visceral
fat gain, with a concurrent risk for increased inflammation.46
Alternatively, the lack of association between patterns of
weight gain and inflammation in the 2 older age strata may
reflect the “proinflammatory state” previously seen with aging
in men due to their higher prevalence of cardiovascular risk
factors and morbidity.47 In the CHNS sample, inflammation and
comorbidities, such as hypertension, hyperlipidemia, and
diabetes mellitus all increase with age,38,39,48 potentially
attenuating the association between weight gain and inflam-
mation in these men.38,39
We also found a relatively small, distinct group of women in
the 18 to <30 and 30 to <40 age strata with initially high weight
gain and subsequent loss (group 5). Despite initial weight gains
that were similar to or higher than those of the highest gainers,
these women had significantly reduced risk of elevated hs-CRP
in 2009 compared to those whoseweight continued to increase
over time. A number of studies have found that CRP declines
with weight loss,19 and these results, along with the finding of
lower risk of hs-CRP amongmen aged 18 to 30 with weight loss
(group 1), indicate that weight loss is beneficial independently
of initial weight and early weight gain. Further, these results are
similar to those from the Coronary Artery Risk Development in
Young Adults (CARDIA) study.49 In 15 years of follow-up,
CARDIA participants with stable or decreased BMI had
markedly lower incidence of metabolic syndrome in middle
age and correspondingly stable or “minimally adverse” changes
in component risk factors.49 Our finding that hs-CRP declines
with weight loss even in groups with high initial gain across age
strata in women suggests that adverse effects of weight gain on
cardiometabolic risk are not immutable, even at older ages.
Taken together, these findings that the association between
weight gain and inflammation varies across age strata in men
and that a weight-gain and weight-loss trajectory associated
with lower CRP is seen only in women, point to significant sex
differences in the association between weight gain and
inflammation in this sample. Sex differences in the association
between weight gain and inflammation have been previously
documented50 and have been attributed to differing amounts
and distribution of adipose tissue in men and women. Adiposity
is more closely associated with inflammation in women than un
men in a number of studies,50–52 even when one is controlling
for metabolic characteristics and exogenous hormone use.53
The mechanism underlying these differences is not well
understood but has been proposed to be linked to leptin,
which varies with fat mass, plays an important role in regulating
the innate immune response, and is significantly correlated
with CRP in women but not men.54
No previous studies have utilized LCTA to identify risk for
inflammation or how this risk may differ between men and
women. However, several studies have incorporated latent
trajectory methods to identify heterogeneity in the develop-
ment of body fatness and obesity across the life course,23,55–
58 or used latent trajectory models to identify weight and BMI
trajectories associated with cardiometabolic risk fac-
tors.25,55,58 Similarly to our findings that steeper weight-gain
trajectories are associated with elevated risk of inflammation,
increasing weight/BMI trajectories were associated with
negative cardiometabolic outcomes despite differences in
sample ages, ethnicities, and lengths of follow-up. Among
middle-aged participants in the Amsterdam Growth and
Health Longitudinal Study, for example, membership in the
“progressively overweight” BMI trajectory, measured from
adolescence into adulthood, was associated with higher
arterial pressure and lower HDL cholesterol at age 42.55
Similarly, middle-aged participants in the National Longitudi-
nal Survey of Youth 1979 Cohort with higher BMI trajectories
from ages 18 to 49 had elevated risk of adverse health
outcomes, measured through a self-rated health survey, at
age 40.58 These studies provide support for our findings that
the pattern and timing of weight gain are important risk
factors for inflammation and for the utility of LCTA in
describing clinically relevant patterns of weight gain.
Similar conclusions may have been drawn from models
incorporating individual intercepts and slopes for those with
steady weight gain; however, LCTA identified unique, easy-to-
interpret classes—recent, rapid weight gain and steep weight
gain—that may facilitate public health intervention. Along with
these strengths, our study has several important limitations.
Despite our overall large study sample size, the number of
individuals in some trajectories was quite small, limiting our
ability to detect significant differences in risk between groups.
However, the smallest groups, the initial weight loss and most
rapid weight gain groups, are clinically relevant, biologically
plausible, and relatively consistent in predicting the risk of
elevated hs-CRP in our simulation study. The analytic sample
differed from the overall study sample in a number of
characteristics that could potentially influence patterns of
weight gain and risk of inflammation. Those excluded from
analysis due to lack of biomarker measures or shorter length of
participation in the study tended to be younger,more urban, and
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less likely to smoke. Despite the wealth of longitudinally
measured weight and lifestyle variables over 18 years in
multiple age groups, biomarkerswere collected for the first time
in 2009, and hs-CRP was the only measured inflammatory
biomarker. The use of a single inflammatory biomarker limits
our ability to more fully describe the pathways linking weight
gain and inflammation. This single hs-CRP measure also limits
our ability to distinguish whether elevated hs-CRP is a
consequence or cause of weight gain, an ongoing debate in
the literature.59,60 Nonetheless, our consistent finding across
age and sex strata that different patterns of weight gain (rapid,
recent gain vs slow and steady) are associated with differential
risk of inflammation independently of weight lends preliminary
support to the more common assertion that CRP is a
consequence of increased adiposity. The use of a cut point
for elevated hs-CRP does not fully capture the range of
association between weight gain and inflammation across the
full range of hs-CRP levels; however, the use of this dichoto-
mous measure is important for identifying cardiometabolic
disease risk, excluding thosewith infectious disease symptoms,
and for establishing the clinical relevance of patterns of weight
change.
Using LCTA, we have identified distinct empirically derived
patterns of weight change in a sample of Chinese adults and
have shown that these differing trajectories of weight change
measured across 18 years are associated with inflammation
risk across sex and age strata. Over one-third of individuals in
the sample belonged to the groups with high weight gain and
increased risk of inflammation. This risk of inflammation
associated with steep rates of weight gain was independent of
baseline weight and smoking status, suggesting that even
after controlling for weight, trajectories of weight gain are
highly informative about risk status. As individuals continue to
transition to Western diets and reduced physical activity,
weight gain patterns may become even more important for
identifying those at risk for inflammation and the development
of cardiometabolic disease.
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Table S1.  Missingness for the Analytic Sample 
Included 
Excluded 
(subjects with at least 
one adult measurement 
less than 66 in 2009 
with no trajectory, or 
pregnant, CRP missing, 
or CRP>10) p-value
N=5536	 N=2613	
2009	Age	 48.8		(	40.6	–	56.6	)	 38.9		(	26.4	–	51.5	)	 <0.0001	
Baseline	Weight	 56.3		(	50.9	–	63.4	)	 59.0		(	52.0	–	66.3	)	 <0.0001	
Ave	Adult	Ht	 160.9		(	155.8	–	167.0	)	 162.8		(	157.0	–	169.5	)	 <0.0001	
Total	HH	Income	 32264		(	17820	–	55067	)	 32543		(	19374	–	53277	)	 0.4418	
2009	Urbanization	
Index	 61.0		(	50.6	–	83.0	)	 75.5		(	54.1	–	89.1	)	 <0.0001	
Ever	Smoke	 0.0014	
0	 68.0%		(3762)	 42.8%		(1119)	
1	 32.0%		(1770)	 16.4%		(429)	
Missing	 	0.1%		(4)	 40.8%		(1065)	
Table	S2:		Distribution	of	Baseline	Wave	by	Age-Sex	Strata	
Baseline	Wave	
N	 1991	 1993	 1997	 2000	 2004	 2006	
F18-30	 936	 39.3%		(368)	 8.0%		(75)	 20.5%		(192)	 14.3%		(134)	 10.4%		(97)	 7.5%		(70)	
F30-40	 1069	 51.9%		(555)	 4.5%		(48)	 16.8%		(180)	 10.5%		(112)	 9.8%		(105)	 6.5%		(69)	
F40-66	 895	 40.1%		(359)	 2.7%		(24)	 19.1%		(171)	 13.6%		(122)	 16.2%		(145)	 8.3%		(74)	
M18-30	 928	 41.1%		(381)	 9.9%		(92)	 21.0%		(195)	 11.0%		(102)	 9.2%		(85)	 7.9%		(73)	
M30-40	 857	 52.2%		(447)	 5.3%		(45)	 17.6%		(151)	 10.6%		(91)	 9.8%		(84)	 4.6%		(39)	
M40-66	 851	 37.7%		(321)	 5.3%		(45)	 19.2%		(163)	 13.2%		(112)	 16.2%		(138)	 8.5%		(72)	
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ESM Figure 1. Relative rank of weight trajectories for elevated CRP 
risk across sex and age strata, results from a simulation study.
Results from a simulation based on random sampling from normal distributions for each trajectory class in each age−sex 
strata, centered at the trajectory−specific estimates of risk of elevated CRP and their respective variances.
  Ranks of the trajectory groups were recorded with rank 1 given 
to the trajectory class with the highest estimated risk of elevated CRP.  This process was repeated 10000 times and 
the frequency of each ranking shown with color coding matching the trajectory figures in Figures 1 and 2, according to the 
frequency that each age−sex−specific trajectory class was assigned a particular rank ranging from low values
 to high values of risk of elevated CRP. 
Supplemental Figure Legends: 
Figure S1: Predicted percent (± 95% confidence interval) with elevated hs-CRP by 
corresponding weight change trajectory across three age strata in men, excluding those 
taking medications with anti-inflammatory properties. Expected percent (± 95% 
confidence interval) is presented for each age strata from left to right corresponding to 
the relative level of weight change in the color-matched trajectory. The number of 
participants in each class is presented at the bottom of each figure. Significant effects of 
the trajectories are indicated with an asterisk. 
Figure S2: Predicted percent (± 95% confidence interval) with elevated hs-CRP by 
corresponding weight change trajectory across three age strata in women, excluding 
those taking medications with anti-inflammatory properties. Expected percent (± 95% 
confidence interval) is presented for each age strata from left to right corresponding to 
the relative level of weight change in the color-matched trajectory. The number of 
participants in each class is presented at the bottom of each figure. Significant effects of 
the trajectories are indicated with an asterisk. 
Figure S3: Relative rank of weight trajectories for elevated CRP risk across sex and 
age strata, results from a simulation study. Results from a simulation based on random 
sampling from normal distributions for each trajectory class in each age−sex strata, 
centered at the trajectory−specific estimates of risk of elevated CRP and their respective 
variances. Ranks of the trajectory groups were recorded with rank 1 given to the 
trajectory class with the highest estimated risk of elevated CRP. This process was 
repeated 10000 times and the frequency of each ranking shown with color coding 
matching the trajectory figures in Figures 1 and 2, according to the frequency that each 
age−sex−specific trajectory class was assigned a particular rank ranging from low 
values to high values of risk of elevated CRP. 
